Insights: White Papers, Research Studies, Books - Vantage Partners

Browse by Category

Our team enjoyed presenting (here's our presentation) at Cambridge Healthtech Institute’s Strategic ...

It’s no great secret that M&A activity in biopharma has been on the rise over the past 12 ...

A Negotiation Scenario Planning Framework In September, the first 10 products were identified for ...

Over the course of our 25 years in the business, we've realized that when a life sciences company ...

Sometimes pharma companies and their partners need to expand “the whole menu, not just the pie” in ...

Experienced leaders who’ve worked across both academia and industry shared their lessons learned ...

Market access negotiations are complex. Depending on the product and competitive context, payers ...

Value-based or pay-for-performance approaches to reimbursement for drugs and devices represent a ...

Originally posted on September 25, 2019 on the Association of Strategic Alliances (ASAP) blog.

As traditional sources of funding dip, universities are scrambling for the cash to support ...

by John Larson and Troy Windt

Strategic partnerships have long been a major feature of the pharmaceutical industry. In-licensing, ...

1 2

The Vantage Partners Insights Center